To print this article, all you need is to be registered or login on Mondaq.com.
Jones Day partner Maureen Bennett talks about how advancements
in digital technology and their clinical trial applications have
introduced additional regulatory regimes in the United States and
the European Union, and describes the differences between the U.S.
and EU models. Maureen also discusses the new clinical trial
regulations expected from the U.S. Food and Drug Administration in
the fall of 2020.
Originally published by Jones Day, on June 2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
In August 2023, we published a blog post about the California Office of Health Care Access and Information's ("OHCA") proposed cost and market impact review ("CMIR") regulations under the California Health Care Quality and Affordability Act ("Proposed Regulations").
You only get to incorporate once, and you want to get it right. In this episode, co-hosts Halle Tecco and Michael Esquivel dive deep into the process of incorporation for startups.
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
